Budesonide
- Generic Name
- Budesonide
- Brand Names
- Airsupra, Breyna, Breztri, Cortiment, Entocort, Pulmicort, Pulmicort Turbuhaler, Rhinocort, Symbicort, Tarpeyo, Uceris, Jorveza, Kinpeygo
- Drug Type
- Small Molecule
- Chemical Formula
- C25H34O6
- CAS Number
- 51333-22-3
- Unique Ingredient Identifier
- Q3OKS62Q6X
- Background
Budesonide is a glucocorticoid that is a mix of the 22R and 22S epimer used to treat inflammatory conditions of the lungs and intestines such as asthma, COPD, Crohn's disease, and ulcerative colitis.
Budesonide was granted FDA approval on 14 February 1994. It is also available in a combination product with formoterol.
- Indication
Budesonide extended release capsules are indicated for the treatment and maintenance of mild to moderate Crohn’s disease. Various inhaled budesonide products are indicated for prophylactic therapy in asthma and to reduce exacerbations of COPD. A budesonide nasal spray is available over the counter for symptoms of hay fever and upper respiratory allergies. E...
- Associated Conditions
- Allergic Reaction, Allergic Rhinitis (AR), Asthma, Bronchoconstriction, Chronic Obstructive Pulmonary Disease (COPD), Collagenous Colitis, Crohn's Disease (CD), Eosinophilic Esophagitis, Exacerbation of asthma, Nasal Congestion, Nasal Polyps, Proteinuria, Pruritus, Rhino Sinusitis, Ulcerative Colitis, Vasomotor Rhinitis, Corticosteroid-responsive dermatoses, Mild Crohn’s Disease, Moderate Crohn’s Disease
- Associated Therapies
- Maintenance therapy
The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis
- Conditions
- Interventions
- First Posted Date
- 2016-03-02
- Last Posted Date
- 2019-09-03
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT02696850
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Altitude Sickness Prevention and Efficacy of Comparative Treatments
- Conditions
- Interventions
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 103
- Registration Number
- NCT02604173
- Locations
- 🇺🇸
Owens Valley Lodge - White Mountain Research Station, Bishop, California, United States
The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-09-29
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- University of Vermont Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02562924
- Locations
- 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States
Budesonide 9 mg Capsules in Active UC
- First Posted Date
- 2015-09-15
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- Dr. Falk Pharma GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT02550418
- Locations
- 🇩🇪
University of Schleswig-Holstein, Lübeck, Schleswig-Holstein, Germany
Small Airways Evaluation and Treatment
- Conditions
- Interventions
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Zhujiang Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT02526758
- Locations
- 🇨🇳
Zhujiang Hospital, Guangzhou, Guangdong, China
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2015-07-22
- Lead Sponsor
- Xiuyi Zhi
- Target Recruit Count
- 73
- Registration Number
- NCT02504801
A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma
- Conditions
- Interventions
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2019-01-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 423
- Registration Number
- NCT02446418
- Locations
- 🇩🇪
GSK Investigational Site, Magdeburg, Germany
Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract
- Conditions
- Interventions
- First Posted Date
- 2015-04-24
- Last Posted Date
- 2018-08-02
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT02425813
- Locations
- 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
- Conditions
- Interventions
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Puma Biotechnology, Inc.
- Target Recruit Count
- 563
- Registration Number
- NCT02400476
- Locations
- 🇺🇸
Compassionate Care Research Group Inc., Riverside, California, United States
🇺🇸Emad Ibrahim, M.D., Inc., Redlands, California, United States
🇺🇸The Oncology Institute of Hope and Innovation, Santa Ana, California, United States
The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2017-07-18
- Lead Sponsor
- Columbia University
- Registration Number
- NCT02357277
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.